Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera
DISC-3405 is an investigational, anti-TMPRSS6 monoclonal antibody designed to increase hepcidin production and suppress serum iron
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Feb 24
DISC-3405 is an investigational, anti-TMPRSS6 monoclonal antibody designed to increase hepcidin production and suppress serum iron
12 Feb 24
New partnership model leverages Aptar Digital Health’s capabilities to support the development and operation of new and existing…
08 Feb 24
Under the terms of the deal, Jazz will secure all rights, patents, title, and interest in exchange for…
08 Feb 24
QSAM is focused on the development of therapeutic radiopharmaceuticals for primary and metastatic bone cancer and its initial…
07 Feb 24
The vaccine’s application is based on the positive findings from a Phase 3 immunogenicity trial that showed an…
07 Feb 24
Demonstrates new engineered functional hair follicles in humanized mice
07 Feb 24
The Ambience AI operating system consists of a holistic suite of applications, designed to alleviate clinician burnout, improve…
06 Feb 24
Myalepta is indicated as a replacement therapy as an adjunct to diet to treat the complications of leptin…
06 Feb 24
The acquisition is expected to further expand and complement Novartis’ oncology pipeline while helping the firm to develop…
06 Feb 24
With this approval, IXCHIQ became the world’s first licensed chikungunya vaccine available to address this unmet medical need